PHARMAC - Latest News [Page 1]

Cystic Fibrosis Medicine Applications To Be Considered By PHARMAC And Medsafe In Parallel

Thursday, 1 April 2021, 2:32 pm | PHARMAC

PHARMAC met this week with Vertex, a supplier of cystic fibrosis medicines, and with Medsafe, the safety and quality regulator for medicines. The meeting was an opportunity to discuss Vertex’s modulator therapy and the process for this type ... More >>

PHARMAC Widens Access To Funded Treatments For Multiple Sclerosis

Friday, 12 February 2021, 10:00 am | PHARMAC

PHARMAC announced today that it will be widening access to all funded multiple sclerosis treatments from 1 March. 1800 people with multiple sclerosis will be able to stay on their treatment for longer, and some who had stopped funded treatment may now ... More >>

Teen Thriving On PHARMAC Funded Medicine

Tuesday, 9 February 2021, 10:42 am | PHARMAC

14-year-old Bruno Cettina is living his best life thanks to a medicine funded by PHARMAC. According to his proud mum, he is a keen sportsman, a musician, an above average student at school and is tackling life with vigour. Bruno is also one of ... More >>

PHARMAC To Fund New Diabetes Medicines With Amended Special Authority Criteria

Monday, 21 December 2020, 12:10 pm | PHARMAC

PHARMAC has approved funding for two new medicines with substantial health benefits for around 53,000 New Zealanders with type 2 diabetes. Read this media release in Te Reo Māori People with high-risk type 2 diabetes, who meet the funding criteria, ... More >>

Dr Crawshaw takes over as PHARMAC’s medical director

Friday, 27 November 2020, 9:59 am | PHARMAC

PHARMAC is pleased to announce that Dr Shirley Crawshaw, seven months after she was appointed, has arrived in New Zealand and commenced her role in the senior leadership team of PHARMAC as the medical director. More >>

PHARMAC Media Release On A New Funding Decision

Wednesday, 11 November 2020, 9:12 am | PHARMAC

From 1 December 2020 a new medicine will be funded by PHARMAC which will help some people with severe haemophilia A. Emicizumab (branded as Hemlibra and supplied by Roche) is a new cutting-edge preventative treatment for people with severe haemophilia ... More >>

Decision Delay For Two New Diabetes Treatments

Thursday, 5 November 2020, 9:14 am | PHARMAC

PHARMAC is taking more time to consider all the feedback it has received on a proposal to fund empagliflozin (with or without metformin) and dulaglutide for New Zealanders with type 2 diabetes. In its proposal to fund these medicines PHARMAC advised that ... More >>

PHARMAC Funding Resources To Focus On Medicines Access Equity

Tuesday, 3 November 2020, 12:31 pm | PHARMAC

PHARMAC is pleased to announce the launch of He Ako Hiringa, a clinical education provider with the mandate to support primary care clinicians address medicines access equity. PHARMAC has funded education and resources to support health professionals ... More >>

Inaugural Chief Advisor, Māori appointed to PHARMAC

Thursday, 8 October 2020, 9:06 am | PHARMAC

A dedicated senior Māori leadership role has been created in PHARMAC demonstrating the strong commitment PHARMAC has to ensuring equitable health outcomes for Māori. More >>

PHARMAC Confirms Their New Way Of Contracting For Medicines

Wednesday, 7 October 2020, 12:03 pm | PHARMAC

PHARMAC is standardising the way medicines are contracted, providing better support to healthcare professionals when they are prescribing medicines for their patients. “I am pleased to confirm that the Principal Supply Status approach will be implemented ... More >>

PHARMAC Acknowledges The Work Of Pharmacists

Thursday, 24 September 2020, 10:08 am | PHARMAC

As millions of pharmacists celebrate the 10th anniversary of World Pharmacists Day tomorrow, PHARMAC’s Chief Executive Sarah Fitt acknowledges the extraordinary work done by New Zealand pharmacists and pharmacy staff this year. “It feels appropriate ... More >>

PHARMAC Seeking Views On Widened Access To Juvenile Idiopathic Arthritis Medicines

Friday, 11 September 2020, 9:08 am | PHARMAC

PHARMAC is looking at widening access to three funded treatments – adalimumab, etanercept and tocilizumab – to enable more young people with juvenile idiopathic arthritis to benefit from these medicines. Juvenile idiopathic arthritis (JIA) is ... More >>

PHARMAC Seeking Views On New Type 2 Diabetes Medicines

Wednesday, 9 September 2020, 12:07 pm | PHARMAC

PHARMAC is looking at funding two new oral medicines with substantial health benefits for the 50,000 New Zealanders with type 2 diabetes. The medicines are empagliflozin (brand name Jardiance), empagliflozin with metformin (brand name Jardiamet), and ... More >>

Oral Contraceptive In Short Supply

Thursday, 6 August 2020, 1:17 pm | PHARMAC

PHARMAC has today advised healthcare professionals that a combined oral contraceptive, Brevinor-1 28 Day, is in short supply due to manufacturing delays. Brevinor-1 28 Day (ethinyloestradiol 35 mcg with norethisterone 1 mg) is a funded combined oral ... More >>

PHARMAC Considering A New Way Of Contracting For Medicines

Tuesday, 4 August 2020, 12:22 pm | PHARMAC

Consultation has gone out today to health professionals and is available on PHARMAC’s website for anyone wanting to have their say about our annual tender process and a proposal to modify our contracting arrangements. Every year PHARMAC invites tenders ... More >>

Paracetamol 500mg Tablets In Short Supply At Pharmacies

Friday, 17 July 2020, 5:05 pm | PHARMAC

PHARMAC has today updated healthcare professionals that paracetamol 500mg tablets for dispensing in pharmacies are in short supply due to global supply issues caused by COVID-19, and work is underway to secure more stock. “COVID-19 is impacting ... More >>

PHARMAC To Remove Medicine Dispensing Restrictions

Thursday, 9 July 2020, 9:39 am | PHARMAC

Most funded medicines will return to all at once dispensing because PHARMAC is removing most of the temporary dispensing restrictions put in place to manage supply during COVID-19. The change will be effective from midnight Friday 31 July 2020. “This ... More >>

Independent Review Of Lamotrigine Sole Supply Decision By PHARMAC

Friday, 5 June 2020, 10:11 am | PHARMAC

An independent review on the lamotrigine sole-supply decision has found that PHARMAC’s processes were evidence based and robust, and of a high standard. The review was published on the PHARMAC website today and shared with people who had been engaging ... More >>

PHARMAC To Fund New Cystic Fibrosis Medicine

Saturday, 30 May 2020, 8:35 am | PHARMAC

From Monday a new medicine is being funded by PHARMAC which will help young children with cystic fibrosis digest their food more easily. Creon Micro, supplied by Mylan, is a modified-release granule formulation of pancreatic enzymes. It enables smaller ... More >>

PHARMAC Places Temporary Dispensing Limits On All Funded Community Medicines

Thursday, 26 March 2020, 1:30 pm | PHARMAC

PHARMAC is placing temporary dispensing limits on all funded community medicines from Friday 27 March 2020. Changes will be made to the Pharmaceutical Schedule, which is a list of the prescription medicines and therapeutic products subsidised by the ... More >>

 

 
 
 
 
 

LATEST HEADLINES

  • PARLIAMENT
  • POLITICS
  • REGIONAL